PAVmed (PAVM) Depreciation & Amortization (CF) (2016 - 2025)
PAVmed has reported Depreciation & Amortization (CF) over the past 5 years, most recently at $18000.0 for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 73.91% year-over-year to $18000.0; the TTM value through Dec 2025 reached $105000.0, down 89.06%, while the annual FY2025 figure was $105000.0, 91.24% down from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $18000.0 at PAVmed, down from $22000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $815000.0 in Q2 2022 and troughed at $10000.0 in Q2 2021.
- A 5-year average of $351263.2 and a median of $216000.0 in 2022 define the central range for Depreciation & Amortization (CF).
- Biggest five-year swings in Depreciation & Amortization (CF): soared 8050.0% in 2022 and later crashed 92.79% in 2025.
- Year by year, Depreciation & Amortization (CF) stood at $166000.0 in 2021, then skyrocketed by 337.35% to $726000.0 in 2022, then dropped by 0.14% to $725000.0 in 2023, then tumbled by 90.48% to $69000.0 in 2024, then plummeted by 73.91% to $18000.0 in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for PAVM at $18000.0 in Q4 2025, $22000.0 in Q3 2025, and $22000.0 in Q2 2025.